InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Carter Jennifer M., Directrice. Director active across 2 companies, notably Augmedix, Inc.. Aggregated, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €300k. Activity tracked since 28 October 2021. The latest transaction was filed on 28 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations1 total
87,500 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-055912:0
Ideal exit: 25 Jul 2022 (T+270)
1 of 1 declaration
About Carter Jennifer M.
Jennifer M. Carter is a Director at Augmedix, Inc. She contributes to the strategy and governance of the company, bringing her expertise in the technology sector. Her role is essential in guiding strategic decisions and ensuring the smooth operation of the organization.
